Announcements Trials
Browse Landscape

Phase

Phase 1/2 4

Status

Unknown 4

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 72Breast Neoplasms 63Neoplasms 59Leukemia, Myeloid, Acute 59Multiple Myeloma 53Colorectal Neoplasms 48Lymphoma 46Recurrence 45Carcinoma, Hepatocellular 45Stomach Neoplasms 43Pancreatic Neoplasms 40Neoplasm Metastasis 39Prostatic Neoplasms 34Melanoma 34Leukemia 30Lymphoma, Non-Hodgkin 27Lymphoma, B-Cell 27Lung Neoplasms 27Precursor Cell Lymphoblastic Leukemia-Lymphoma 24Glioblastoma 24Ovarian Neoplasms 23Lymphoma, Large B-Cell, Diffuse 21Esophageal Neoplasms 21Carcinoma, Renal Cell 20Myelodysplastic Syndromes 19Leukemia, Lymphocytic, Chronic, B-Cell 19Hematologic Neoplasms 19Colonic Neoplasms 19Head and Neck Neoplasms 18Lymphoma, Mantle-Cell 17

Interventions

Drug Therapy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1/2 × Unknown × Precision Cell Immunotherapy × Clear all
NCT02873416 2016-10-07

Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Lung Cancer

Ningbo Cancer Hospital

Phase 1/2 Unknown
40 enrolled
Thoracic

Precision Cell Immunotherapy

NCT02873442 2016-10-07

Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer

Ningbo Cancer Hospital

Phase 1/2 Unknown
40 enrolled

Precision Cell Immunotherapy

NCT02873520 2016-10-07

Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Gastric Cancer

Ningbo Cancer Hospital

Phase 1/2 Unknown
40 enrolled
Gastrointestinal

Precision Cell Immunotherapy

NCT02862561 2016-09-02

Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Gastric Cancer

Shanghai International Medical Center

Phase 1/2 Unknown
40 enrolled

Precision Cell Immunotherapy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡